Subscribe / Renew |
|
Contact Us |
|
► Subscribe to our Free Weekly Newsletter |
home | Welcome, sign in or click here to subscribe. | login |
July 27, 2017
OLYMPIA (AP) — Washington state will keep a small fraction of a $280 million national settlement involving a pharmaceutical company accused of committing fraud by promoting two drugs for unapproved cancer treatments.
Celgene Corp. denied wrongdoing but agreed to pay the federal government, 28 states and the District of Columbia to settle a whistleblower claim brought by a former company saleswoman. Washington state will keep about $368,000 for its Medicaid program under the settlement announced Tuesday. The whistleblower could be entitled to as much as $84 million.
. . .